Cognition research
Semax vs Cerebrolysin
Synthetic neuropeptide research beside neuropeptide mixture literature.
Overview
This comparison separates Semax and Cerebrolysin for laboratory reference—not product selection.
Semax: and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation modifications.
Cerebrolysin: Standardized neuropeptide preparation containing bioactive peptides and amino acids exhibiting neurotrophic and neuroprotective properties for stroke recovery, traumatic brain inju…
Differences
- Both appear in Cognition & neuromodulation literature, but mechanistic framing differs.
- The useful distinction is research question and receptor context—not relative potency or practical ranking.
Mechanism
Semax: and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation modifications.
Cerebrolysin: Standardized neuropeptide preparation containing bioactive peptides and amino acids exhibiting neurotrophic and neuroprotective properties for stroke recovery,…
Pharmacology
Semax: and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation modifications.
Cerebrolysin: IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors.
Research
Semax: Cognition & neuromodulation: and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation m…
Cerebrolysin: Cognition & neuromodulation: Standardized neuropeptide preparation containing bioactive peptides and amino acids exhibiting neurotrophic and neuroprotective properties fo…
Summary
Distinction
- AXIOM does not provide dosing, administration, or protocol guidance.
- Catalogue links appear only where AXIOM lists a research-use product.
- Reference-only compounds remain comparison terms without implying availability.
References
- pubmed.ncbi.nlm.nih.gov/29798983/
- pubmed.ncbi.nlm.nih.gov/30225715/
- pubmed.ncbi.nlm.nih.gov/24661604/
- pubmed.ncbi.nlm.nih.gov/16996037/
- pubmed.ncbi.nlm.nih.gov/9173745/
- pubmed.ncbi.nlm.nih.gov/29248999/
- pubmed.ncbi.nlm.nih.gov/36979317/
- pubmed.ncbi.nlm.nih.gov/28458521/
Questions
Does this page recommend Semax or Cerebrolysin?
No. It is an editorial comparison for research context only.
Does AXIOM provide protocol guidance?
No. Protocol and dosing decisions belong with qualified laboratory teams and source literature.
Available from AXIOM
Catalogue
Labelled strengths and batch records where available.